医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
6期
1062-1064
,共3页
肺肿瘤%腺癌%受体,表皮生长因子%蛋白酪氨酸激酶类
肺腫瘤%腺癌%受體,錶皮生長因子%蛋白酪氨痠激酶類
폐종류%선암%수체,표피생장인자%단백락안산격매류
Lung Neoplasms%Adenocarcinoma%Receptor,Epidermal Growth Factor%Protein-Tyro-sine Kinases
【目的】探讨肺腺癌患者表皮生长因子受体酪氨酸激酶结构域(EGFR-TKD)突变与放射敏感性的关系。【方法】将36例肺腺癌并 EGFR-TKD突变者列为观察组,24例无突变者列为对照组。对两组患者肺部原发病灶均采用三维适形放射治疗,放疗结束后1个月复查胸部 CT评价近期疗效。【结果】全部患者均顺利完成治疗,观察组完全缓解(CR)10例,部分缓解(PR)24例,稳定2例,进展0例,近期总有效率(CR+PR)94.4%。对照组CR 7例,PR 10例,稳定6例,进展1例,近期总有效率70.8%。两组患者近期有效率比较差异有显著性(P<0.05)。【结论】肺腺癌 EGFR-TKD突变患者的近期放疗效果好,提示 EGFR-TKD突变是预测放射敏感性的重要指标。
【目的】探討肺腺癌患者錶皮生長因子受體酪氨痠激酶結構域(EGFR-TKD)突變與放射敏感性的關繫。【方法】將36例肺腺癌併 EGFR-TKD突變者列為觀察組,24例無突變者列為對照組。對兩組患者肺部原髮病竈均採用三維適形放射治療,放療結束後1箇月複查胸部 CT評價近期療效。【結果】全部患者均順利完成治療,觀察組完全緩解(CR)10例,部分緩解(PR)24例,穩定2例,進展0例,近期總有效率(CR+PR)94.4%。對照組CR 7例,PR 10例,穩定6例,進展1例,近期總有效率70.8%。兩組患者近期有效率比較差異有顯著性(P<0.05)。【結論】肺腺癌 EGFR-TKD突變患者的近期放療效果好,提示 EGFR-TKD突變是預測放射敏感性的重要指標。
【목적】탐토폐선암환자표피생장인자수체락안산격매결구역(EGFR-TKD)돌변여방사민감성적관계。【방법】장36례폐선암병 EGFR-TKD돌변자렬위관찰조,24례무돌변자렬위대조조。대량조환자폐부원발병조균채용삼유괄형방사치료,방료결속후1개월복사흉부 CT평개근기료효。【결과】전부환자균순리완성치료,관찰조완전완해(CR)10례,부분완해(PR)24례,은정2례,진전0례,근기총유효솔(CR+PR)94.4%。대조조CR 7례,PR 10례,은정6례,진전1례,근기총유효솔70.8%。량조환자근기유효솔비교차이유현저성(P<0.05)。【결론】폐선암 EGFR-TKD돌변환자적근기방료효과호,제시 EGFR-TKD돌변시예측방사민감성적중요지표。
[Obj ective]To explore the relationship between epidermal growth factor receptor tyrosine kinase domain (EGFR-TKD)mutation and radiosensitivity in patients with lung adenocarcinoma.[Methods]A total of 3 6 lung adeno-carcinoma patients with EGFR-TKD mutation were selected as the observation group.A total of 24 patients without EG-FR-TKD mutation were selected as the control group.Three-dimensional conformal radiotherapy was performed in prima-ry lung lesions of patients in 2 groups.Chest CT reexamination was performed 1 month after radiotherapy and used to e-valuate the short-term efficacy.[Results]All patients completed the treatment smoothly.In the observation group,1 0 patients were complete remission(CR),and 24 patients were partial remission(PR),and 2 patients were stable,and no one was developed,and the short-term total effective rate(CR+PR)was 94.4%.In the control group,7 patients were complete remission(CR),and 1 0 patients were partial remission(PR),and 6 patients were stable,and 1 patient was de-veloped,and the total short-term effective rate was 70.8%.There was significant difference in the short-term efficacy be-tween two groups(P<0.05).[Conclusion]Lung adenocarcinoma patients with EGFR-TKD mutation have better short-term efficacy.It suggests that EGFR-TKD mutation is an important indicator of predicting radiosensitivity.